Effects of Release-Active Antibodies to CD4 Receptor on the Level of lck-Kinase in Cultured Mononuclear Cells from Human Peripheral Blood


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

For evaluation of effects of release-active antibodies to CD4 on cultured lymphocytes from human peripheral blood, we measured intracellular content of lck-kinase cell-based ELISA. In cells treated with release-active antibodies to CD4, the content of intracellular lck-kinase significantly (p<0.01) decreased in comparison with the control (purified water processed in a similar way). Phytohemagglutinin had no effect on the concentration of lck-kinase in cells. The decrease in the content of CD4-associated lck protein suggests that the preparation enhanced intracellular coupling of lck-kinase with T-cell receptor and potentiated T-cell immune response.

作者简介

A. Emel’yanova

1Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathophysiology, Research Institute of General Pathology and Pathophysiology

编辑信件的主要联系方式.
Email: agemelyanova@gmail.com
俄罗斯联邦, Moscow

V. Grechenko

Research and Production Company Materia Medica Holding

Email: agemelyanova@gmail.com
俄罗斯联邦, Moscow

N. Petrova

1Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathophysiology, Research Institute of General Pathology and Pathophysiology

Email: agemelyanova@gmail.com
俄罗斯联邦, Moscow

I. Shilovskii

State Research Centre Institute of Immunology, Federal Medical-Biological Agency of the Russian Federation

Email: agemelyanova@gmail.com
俄罗斯联邦, Moscow

E. Gorbunov

Research and Production Company Materia Medica Holding

Email: agemelyanova@gmail.com
俄罗斯联邦, Moscow

S. Tarasov

Research and Production Company Materia Medica Holding

Email: agemelyanova@gmail.com
俄罗斯联邦, Moscow

M. Khaitov

State Research Centre Institute of Immunology, Federal Medical-Biological Agency of the Russian Federation

Email: agemelyanova@gmail.com
俄罗斯联邦, Moscow

S. Morozov

1Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathophysiology, Research Institute of General Pathology and Pathophysiology

Email: agemelyanova@gmail.com
俄罗斯联邦, Moscow

O. Epshtein

1Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathophysiology, Research Institute of General Pathology and Pathophysiology

Email: agemelyanova@gmail.com
俄罗斯联邦, Moscow


版权所有 © Springer Science+Business Media New York, 2017
##common.cookie##